Link Pharma Chem logo

Link Pharma Chem financials and balance sheet

BSE: 524748Chemicals & PetrochemicalsSmall Cap

Last close ₹24.04down ₹1.70 (6.60%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹25.74.

52-week range of traded prices to 23 Oct 2026
₹21.00Low, 17 Mar 2026₹36.50High, 24 Oct 2025
Market cap
₹11 Cr4,498th largest listed
P/E
Lossover the last 12 months
P/B
0.8
Dividend yield
Nonein the last 12 months
ROE
−0.1%
ROCE
1.2%
Debt to equity
0.57
Volume, BSE
743

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Link Pharma Chem annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Back to profit in the year to Mar 2026, ₹0.08 CrA loss in 2 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2018, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue27
  2. Materials and goods−11
  3. Employee costs−6.1
  4. Other expenses−9.1
  5. Operating profit1.4
  6. Depreciation−1.0
  7. Other income+0.2
  8. One-off items0.0
  9. Finance costs−0.5
  10. Profit before tax0.1
  11. Tax−0.1
  12. Net profit0.1

What the company owns

  • Plant, investments and other assets₹14 Cr
  • Receivables₹5 Cr
  • Inventory₹5 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹13 Cr
  • Borrowings₹7 Cr
  • Owed to suppliers₹3 Cr
  • Other liabilities₹2 Cr

Profit and loss

Standalone, ₹ crore, years to March.Link Pharma Chem quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 18 JunMar 2021Filed 31 MayMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 1 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue from operations17.824.024.525.534.853.638.829.925.427.4
15.821.222.522.831.850.036.030.525.326.0
Materials and goods bought5.49.911.39.917.836.421.416.712.510.8
Employee costs––4.75.05.65.85.75.55.46.1
Other expenses––6.47.98.47.89.08.47.49.1
Operating profit before depreciation2.02.82.02.63.03.52.7−0.60.11.4
Operating margin11.3%11.6%8.2%10.3%8.5%6.6%7.0%−2.2%0.5%5.3%
Materials, % of revenue––46.2%38.9%51.1%68.0%55.1%55.8%49.3%39.2%
Employee costs, % of revenue––19.3%19.6%16.2%10.8%14.7%18.4%21.2%22.2%
Other expenses, % of revenue––26.3%31.2%24.2%14.6%23.2%27.9%29.0%33.3%
Depreciation and amortisation0.80.90.90.90.90.90.91.00.91.0
Operating profit after depreciation1.21.91.11.72.12.61.8−1.7−0.80.5
Other income0.10.10.20.10.00.5−0.10.60.20.2
Finance costs0.80.60.40.40.40.50.80.90.80.5
One-off items––0.00.00.00.00.00.00.00.0
Profit before tax0.51.40.91.41.72.60.9−1.9−1.40.1
0.20.20.30.50.60.70.2−0.6−0.40.1
Net profit0.31.10.70.91.11.90.7−1.4−1.00.1
Other comprehensive income––0.00.10.00.0−0.10.00.00.1
Total comprehensive income––0.71.11.11.90.6−1.3−1.00.1
Net margin1.6%4.7%2.7%3.7%3.1%3.5%1.7%−4.6%−4.0%0.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations12.212.811.814.419.218.125.919.112.3
11.112.310.114.217.415.923.619.812.5
Materials and goods bought–7.25.07.78.97.414.010.94.8
Employee costs–1.21.31.52.6–2.93.33.4
Other expenses–4.03.85.16.0–6.85.64.3
Operating profit before depreciation1.10.51.70.21.82.22.3−0.8−0.2
Operating margin9.0%3.7%14.5%1.3%9.2%12.1%9.0%−4.1%−1.3%
Materials, % of revenue–55.9%42.0%53.4%46.2%–53.8%57.3%39.2%
Employee costs, % of revenue–9.2%11.1%10.1%13.4%–11.1%17.5%27.5%
Other expenses, % of revenue–31.2%32.4%35.1%31.2%–26.1%29.3%34.6%
Depreciation and amortisation0.60.50.50.50.50.60.81.10.9
Operating profit after depreciation0.50.01.2−0.31.31.61.5−1.9−1.1
Other income0.70.20.11.10.30.10.30.22.7
Finance costs0.50.50.50.60.91.21.11.40.9
Profit before tax0.7−0.30.80.20.70.50.7−3.10.7
Tax0.10.0––0.20.20.2−0.90.1
Net profit0.6−0.20.80.20.50.30.5−2.20.6
Net margin5.2%−1.4%6.7%1.5%2.6%1.6%2.0%−11.5%4.8%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 10 JunMar 2020Filed 18 JunMar 2021Filed 31 MayMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 1 JulMar 2025Filed 12 JunMar 2026Filed 21 May
10.411.412.614.515.013.712.712.8
Share capital4.44.44.44.44.44.44.44.4
Reserves5.97.08.110.010.69.38.28.3
2.43.23.26.48.89.25.87.3
4.93.59.410.614.511.010.111.2
2.74.14.23.92.91.20.60.9
Total assets18.019.026.229.032.526.023.325.0
10.89.910.915.414.914.412.113.6
7.29.115.313.617.511.511.211.3
Net debt2.21.1−1.75.58.69.15.76.7
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 31 MayMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 1 JulMar 2025Filed 12 JunMar 2026Filed 21 May
4.85−1.25−1.71−0.032.692.15
5.194.39−1.860.922.872.20
2.180.39−4.430.932.550.47
Receivables−0.560.191.32−1.580.11−0.45
Inventories−0.872.26−7.496.040.470.71
Payables5.87−1.710.65−4.912.000.09
Other working capital−2.26−0.341.091.38−0.040.12
Tax paid−0.48−0.67−0.41−0.37−0.03−0.02
Interest paid0.000.00−0.080.000.000.00
Capital spending1.811.160.890.950.262.10
Free cash flow3.05−2.41−2.60−0.982.430.05
−2.17−4.98−0.080.411.53−2.66
−0.332.271.61−0.41−4.210.99
Dividends paid0.000.000.000.000.000.00
Shares bought back0.000.000.000.000.000.00
Shares issued0.000.000.000.000.000.00
Net change in cash2.35−3.95−0.17−0.030.000.48
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 18 JunMar 2021Filed 31 MayMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 1 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Earnings per share₹0.65₹2.56₹1.48₹2.14₹2.44₹4.24₹1.47−₹3.07−₹2.31₹0.17
Diluted earnings per share₹0.65₹2.56₹1.48₹2.14₹2.44₹4.24₹1.47−₹3.07−₹2.31₹0.17
Book value per share––₹23.38₹25.75₹28.29₹32.60₹33.87₹30.87₹28.51₹28.80
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)5.812.211.17.610.517.916.318.715.010.1

Ratios

Standalone, years to March.Link Pharma Chem PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 18 JunMar 2021Filed 31 MayMar 2022Filed 10 JunMar 2023Filed 30 MayMar 2024Filed 1 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue growth–––4.0%36.7%53.9%−27.6%−22.9%−14.9%7.9%
Operating profit growth–37.5%−27.3%30.3%13.0%19.0%−23.2%––1,013.8%
Net profit growth−50.8%290.0%−42.0%44.3%14.2%73.4%−65.2%–––
Earnings per share growth–293.8%−42.2%44.6%14.0%73.8%−65.3%–––
––6.3%8.7%9.0%13.9%4.4%−9.5%−7.8%0.6%
–––2.4 pts0.3 pts4.9 pts−9.5 pts−13.9 pts1.7 pts8.4 pts
From the net margin–––2.5 pts−1.4 pts1.2 pts−7.2 pts−16.4 pts1.1 pts8.3 pts
From asset turnover–––0.1 pts0.9 pts2.6 pts−2.3 pts2.3 pts−0.1 pts0.1 pts
From borrowing–––−0.2 pts0.9 pts1.1 pts0.1 pts0.2 pts0.7 pts0.0 pts
Return on capital employed––8.8%11.6%13.3%12.5%7.5%−7.3%−4.4%2.3%
Cash conversion––––447.2%−66.5%−260.9%––2,794.8%
Interest cover1.53.12.94.74.85.82.4––0.9
Debt to equity––0.230.280.250.440.580.670.460.57
Receivable days––4572583734637270
Inventory days––92605148209136167170
Payable days––1091111414811338101110
Cash conversion cycle, days––2921−3136131160138130
Working capital days––41511038911059281
Asset turnover––1.361.381.541.941.261.021.031.14
Assets per rupee of net worth––1.731.691.882.042.082.031.871.90
Sales per rupee of plant––2.682.894.006.104.313.012.742.64
Capital spending to depreciation––––2.071.250.970.920.272.14
Plant being built, % of plant in use––4.7%0.0%0.0%2.4%0.0%0.0%0.0%0.0%
Revenue growth is left blank for the year to Mar 2017: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Revenue growth is left blank for the years to Mar 2018 and Mar 2019: between the two periods excise duty was taken out of revenue when GST replaced it, so the two are on different bases and the change is not worked out. Interest cover is left blank for the years to Mar 2024 and Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.3%
Cash from operations against operating profit
148.9%
Measure10 years5 years3 years
Revenue growth, yearly rate8.3%−4.7%−10.9%
Profit growth, yearly rate−18.5%−41.1%−51.0%
Return on equity, average–0.3%−5.6%
Return on capital employed, average–2.1%−3.2%
Operating margin, average6.7%3.4%1.2%
Net margin, average1.3%−0.6%−2.8%
Asset turnover, average–1.281.06
Cash conversion cycle, days, average–119143
Debt to equity, average–0.540.57

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1.854.802.15
Cash from investing−5.77−0.72−2.66
Cash from financing0.25−3.630.99
Capital spending5.363.312.10
Dividends paid0.000.000.00
Shares bought back0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised––1.93
Borrowings repaid5.921.970.40

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––753387
Altman Z-scorePublished threshold 1.81––3.093.132.763.552.492.462.402.16
Beneish M-scorePublished threshold −1.78––––−2.74−1.62−2.76−2.27−3.43−2.99
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−7.0729.407.93−5.96−21.292.43
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.52−2.55––
Receivables growth less revenue growthOur threshold 0 percentage points–––60.14−25.52−57.21−4.7064.7812.32−2.61
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−30.66−26.28−14.39198.86−27.4017.201.83
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−2.415.630.39−2.92−4.461.050.19
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.000.210.000.000.000.00
Effective tax ratePublished threshold 17.16 per cent37.2817.2129.2334.1035.3628.2226.19––43.11
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––2.49−19.64––28.15
A threshold marked as ours has no published figure; it is the line we read the check against.